119 related articles for article (PubMed ID: 37572452)
21. The role of globular heads of the C1q receptor in HPV 16 E2-induced human cervical squamous carcinoma cell apoptosis is associated with p38 MAPK/JNK activation.
Gao LJ; Gu PQ; Zhao W; Ding WY; Zhao XQ; Guo SY; Zhong TY
J Transl Med; 2013 May; 11():118. PubMed ID: 23651874
[TBL] [Abstract][Full Text] [Related]
22. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
Ryzhakova OS; Solov'eva NI
Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343
[TBL] [Abstract][Full Text] [Related]
23. CD71
Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
Mol Cancer Res; 2019 Sep; 17(9):1867-1880. PubMed ID: 31235657
[TBL] [Abstract][Full Text] [Related]
24. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
25. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
26. A study on screening and antitumor effect of CD55-specific ligand peptide in cervical cancer cells.
Li G; Yin Q; Ji H; Wang Y; Liu H; Jiang L; Zhu F; Li B
Drug Des Devel Ther; 2018; 12():3899-3912. PubMed ID: 30519000
[TBL] [Abstract][Full Text] [Related]
27. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
Ravindranath NM; Shuler C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
[TBL] [Abstract][Full Text] [Related]
28. Metabolic rewiring is associated with HPV-specific profiles in cervical cancer cell lines.
Pappa KI; Daskalakis G; Anagnou NP
Sci Rep; 2021 Sep; 11(1):17718. PubMed ID: 34489482
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of lncRNAs microarray profile and mRNA-lncRNA co-expression in oncogenic HPV-positive cervical cancer cell lines.
Yang L; Yi K; Wang H; Zhao Y; Xi M
Oncotarget; 2016 Aug; 7(31):49917-49929. PubMed ID: 27363024
[TBL] [Abstract][Full Text] [Related]
30. Integrated HPV genomes tend to integrate in gene desert areas in the CaSki, HeLa, and SiHa cervical cancer cell lines.
Diao MK; Liu CY; Liu HW; Li JT; Li F; Mehryar MM; Wang YJ; Zhan SB; Zhou YB; Zhong RG; Zeng Y
Life Sci; 2015 Apr; 127():46-52. PubMed ID: 25747255
[TBL] [Abstract][Full Text] [Related]
31. Combined ultrasound-curcumin treatment of human cervical cancer cells.
Carr KR; Ioffe YJ; Filippova M; Duerksen-Hughes P; Chan PJ
Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():96-101. PubMed ID: 26262768
[TBL] [Abstract][Full Text] [Related]
32. HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis.
Wang J; Xiang F; Liu X; Ma X; Cai X; Yang Y; Shen X; Yuan C; Xiang Y; Xiao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760214
[TBL] [Abstract][Full Text] [Related]
33. A1E reduces stemness and self-renewal in HPV 16-positive cervical cancer stem cells.
Kwon T; Bak Y; Ham SY; Yu DY; Yoon DY
BMC Complement Altern Med; 2016 Feb; 16():42. PubMed ID: 26832364
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
35. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
Iborra A; Mayorga M; Llobet N; Martínez P
Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
[TBL] [Abstract][Full Text] [Related]
36. Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.
Juhl H; Helmig F; Baltzer K; Kalthoff H; Henne-Bruns D; Kremer B
J Surg Oncol; 1997 Mar; 64(3):222-30. PubMed ID: 9121154
[TBL] [Abstract][Full Text] [Related]
37. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy.
García-Zepeda SP; García-Villa E; Díaz-Chávez J; Hernández-Pando R; Gariglio P
Eur J Cancer Prev; 2013 Nov; 22(6):577-84. PubMed ID: 23603746
[TBL] [Abstract][Full Text] [Related]
39. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK
Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994
[TBL] [Abstract][Full Text] [Related]
40. Cytokines affect resistance of human renal tumour cells to complement-mediated injury.
Blok VT; Gelderman KA; Tijsma OH; Daha MR; Gorter A
Scand J Immunol; 2003 Jun; 57(6):591-9. PubMed ID: 12791098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]